We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GLAD:NASDAQGladstone Capital Corporation Analysis

Data as of 2026-04-06 - not real-time

$17.90

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Gladstone Capital (GLAD) trades near $17.90, well above its DCF‑derived fair value of roughly $11.20, indicating the market is pricing in a premium despite modest revenue growth of 11.6% and a strong dividend yield of over 10%. Technical indicators show a bearish bias: the price sits below the 20‑day SMA (17.63) and the 50‑day SMA (18.59), the 200‑day SMA remains at $22.09, and the MACD line is negative though the histogram has turned slightly positive, suggesting limited upside momentum. The RSI at 50.5 points to a neutral stance, while volume is increasing, supporting the current price level but not enough to reverse the downtrend. Fundamentally, the company’s P/E of 11.3 is below the industry average of 16.6, yet the high payout ratio of 122% raises concerns about dividend sustainability, especially given negative operating cash flow and a debt‑to‑equity ratio above 80%. The balance sheet shows $405.9 M of debt versus $4.2 M of cash, creating leverage risk. Volatility is elevated at 27.7% over the past 30 days, though beta is modest at 0.81, reflecting lower systematic risk but higher idiosyncratic risk. The stock’s upside potential from the DCF model is roughly 21%, yet the current market sentiment is “Extreme Greed,” which may be overstating near‑term expectations. Overall, GLAD appears overvalued relative to intrinsic estimates, with a dividend that may be unsustainable and a bearish technical outlook, suggesting caution for investors.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 4/10

Key Factors

  • price below short‑term moving averages
  • bearish technical trend
  • unsustainable dividend payout

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • moderate revenue growth
  • valuation gap between market price and DCF
  • high leverage and cash flow concerns

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • potential for dividend adjustments improving sustainability
  • stable sector fundamentals for BDCs
  • ongoing credit risk from high debt levels

Key Metrics & Analysis

Financial Health

Revenue Growth11.60%
Profit Margin38.91%
P/E Ratio11.3
ROE7.16%
ROA4.96%
Debt/Equity80.14
P/B Ratio0.8
Op. Cash Flow$-63284000
Free Cash Flow$29.7M
Industry P/E16.6

Technical Analysis

TrendBearish
RSI50.5
Support$16.54
Resistance$18.34
MA 20$17.63
MA 50$18.59
MA 200$22.09
MACDBullish
VolumeIncreasing
Fear & Greed Index78.8

Valuation

Fair Value$11.20
Target Price$21.67
Upside/Downside21.04%
GradeOvervalued
TypeValue
Dividend Yield10.55%

Risk Assessment

Beta0.81
Volatility27.68%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.